skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Skin Cancer (PDQ®): Treatment
Patient VersionHealth Professional VersionEn EspañolLast Modified: 06/06/2003




General Information






Cellular Classification






Stage Information






Treatment Option Overview






Basal Cell Carcinoma of the Skin






Squamous Cell Carcinoma of the Skin






Actinic Keratosis






Changes to This Summary (06/06/2003)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
October is Breast Cancer Awareness Month

NCI Annual Progress Report on Cancer Research 2003

Women, Tobacco and Cancer: Agenda for 21st Century

Past Highlights
Need Help?
General Information

Note: Separate PDQ summaries on Screening for Skin Cancer and Prevention of Skin Cancer are also available.

Basal cell carcinoma is the most common form of skin cancer. The second most common type of skin malignancy is squamous cell carcinoma. Although these 2 types of skin cancer are the most common of all malignancies, they account for less than 0.1% of patient deaths due to cancer. Both of these types of skin cancer are more likely to occur in individuals of light complexion who have had significant exposure to sunlight, and both types of skin cancers are more common in the southern latitudes of the Northern hemisphere.[1] The overall cure rate for both types of skin cancer is directly related to the stage of the disease and the type of treatment used.[2] However, since neither basal cell carcinoma nor squamous cell carcinoma are reportable diseases, precise 5-year cure rates are not known. Although basal cell carcinoma and squamous cell carcinoma are by far the most frequent types of skin tumors, the skin can also be the site of a large variety of malignant neoplasms. These other types of malignant disease include malignant melanoma, cutaneous T-cell lymphomas (mycosis fungoides), Kaposi’s sarcoma, extramammary Paget’s disease, apocrine carcinoma of the skin, and metastatic malignancies from various primary sites. (Refer to the PDQ summaries on Melanoma Treatment; Mycosis Fungoides and the Sézary Syndrome Treatment; and Kaposi’s Sarcoma Treatment for more information.) Guidelines for the care of cutaneous squamous cell carcinoma have been published.[3]

References

  1. Wagner RF, Casciato DA: Skin cancers. In: Casciato DA, Lowitz BB, eds.: Manual of Clinical Oncology. 4th ed. Philadelphia, Pa: Lippincott, Williams, and Wilkins, 2000, pp 336-373. 

  2. Rowe DE, Carroll RJ, Day CL Jr: Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15 (3): 315-28, 1989.  [PUBMED Abstract]

  3. Guidelines of care for cutaneous squamous cell carcinoma. Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. J Am Acad Dermatol 28 (4): 628-31, 1993.  [PUBMED Abstract]

Back to TopBack to Top

Next Section >

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov